Problems in Diagnosing Scabies, a Global Disease in Human and Animal Populations
Top Cited Papers
- 1 April 2007
- journal article
- review article
- Published by American Society for Microbiology in Clinical Microbiology Reviews
- Vol. 20 (2), 268-279
- https://doi.org/10.1128/cmr.00042-06
Abstract
SUMMARY: Scabies is a worldwide disease and a major public health problem in many developing countries, related primarily to poverty and overcrowding. In remote Aboriginal communities in northern Australia, prevalences of up to 50% among children have been described, despite the availability of effective chemotherapy. Sarcoptic mange is also an important veterinary disease engendering significant morbidity and mortality in wild, domestic, and farmed animals. Scabies is caused by the ectoparasitic mite Sarcoptes scabiei burrowing into the host epidermis. Clinical symptoms include intensely itchy lesions that often are a precursor to secondary bacterial pyoderma, septicemia, and, in humans, poststreptococcal glomerulonephritis. Although diagnosed scabies cases can be successfully treated, the rash of the primary infestation takes 4 to 6 weeks to develop, and thus, transmission to others often occurs prior to therapy. In humans, the symptoms of scabies infestations can mimic other dermatological skin diseases, and traditional tests to diagnose scabies are less than 50% accurate. To aid early identification of disease and thus treatment, a simple, cheap, sensitive, and specific test for routine diagnosis of active scabies is essential. Recent developments leading to the expression and purification of S. scabiei recombinant antigens have identified a number of molecules with diagnostic potential, and current studies include the investigation and assessment of the accuracy of these recombinant proteins in identifying antibodies in individuals with active scabies and in differentiating those with past exposure. Early identification of disease will enable selective treatment of those affected, reduce transmission and the requirement for mass treatment, limit the potential for escalating mite resistance, and provide another means of controlling scabies in populations in areas of endemicity.Keywords
This publication has 132 references indexed in Scilit:
- Evaluation of an enzyme‐linked immunosorbent assay (ELISA) for the serological diagnosis of canine sarcoptic mangeVeterinary Dermatology, 1996
- Dermatopathology in Historical PerspectiveThe American Journal of Dermatopathology, 1991
- Comparison of Crotamiton 10% Cream (Eurax) and Permethrin 5% Cream (Elimite) for the Treatment of Scabies in ChildrenPediatric Dermatology, 1990
- Immunology of scabiesParasitology Today, 1986
- Cross infestivity of Sarcoptes scabieiJournal of the American Academy of Dermatology, 1984
- Host-seeking behavior of Sarcoptes scabieiJournal of the American Academy of Dermatology, 1984
- Survival and infestivity of Sarcoptes scabiei var. canis and var. hominisJournal of the American Academy of Dermatology, 1984
- A comparative trial of three treatment schedules for the eradication of scabiesJournal of the American Academy of Dermatology, 1983
- Eradication of scabies with a single treatment scheduleJournal of the American Academy of Dermatology, 1983
- The Burrow Ink Test and the scabies miteJournal of the American Academy of Dermatology, 1981